Renaissance Technologies’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.64M | Buy |
|
|||||
|
2025
Q1 | $1.99M | Sell |
|
|||||
|
2024
Q4 | $2.57M | Sell |
|
|||||
|
2024
Q3 | $1.05M | Buy |
|
|||||
|
2024
Q2 | $1.14M | Sell |
|
|||||
|
2024
Q1 | $2.35M | Buy |
|
|||||
|
2023
Q4 | $1.43M | Buy |
|
|||||
|
2023
Q3 | $1.51M | Buy |
|
|||||
|
2023
Q2 | $1.75M | Buy |
|
|||||
|
2023
Q1 | $1.6M | Buy |
|
|||||
|
2022
Q4 | $896K | Sell |
|
|||||
|
2022
Q3 | $812K | Buy |
|
|||||
|
2022
Q2 | $565K | Sell |
|
|||||
|
2022
Q1 | $1.2M | Buy |
|
|||||
|
2021
Q4 | $1.8M | Buy |
|
|||||
|
2021
Q3 | $2.51M | Buy |
|
|||||
|
2021
Q2 | $2.11M | Buy |
|
|||||
|
2021
Q1 | $2.15M | Sell |
|
|||||
|
2020
Q4 | $3.12M | Buy |
|
|||||
|
2020
Q3 | $3.58M | Buy |
|
|||||
|
2020
Q2 | $4.24M | Buy |
|
|||||
|
2020
Q1 | $2.32M | Buy |
|
|||||
|
2019
Q4 | $3.06M | Buy |
|
|||||
|
2019
Q3 | $1.35M | Buy |
|
|||||
|
2019
Q2 | $1.03M | Buy |
|
|||||
|
2019
Q1 | $1.05M | Buy |
|
|||||
|
2018
Q4 | $744K | Buy |
|
|||||
|
2018
Q3 | $1.36M | Buy |
|
|||||
|
2018
Q2 | $1.48M | Buy |
|
|||||
|
2018
Q1 | $1.05M | Buy |
|
|||||
|
2017
Q4 | $1.22M | Buy |
|
|||||
|
2017
Q3 | $1.15M | Buy |
|
|||||
|
2017
Q2 | $1.02M | Buy |
|
|||||
|
2017
Q1 | $277K | Sell |
|
|||||
|
2016
Q4 | $519K | Buy |
|
|||||
|
2016
Q3 | $498K | Buy |
|
|||||
|
2016
Q2 | $276K | Buy |
|